MPhil: A 2:1 honours degree, or international equivalent, in a science or medicine related subject. PhD: A 2:1 honours degree, or international equivalent. Further research experience or a master’s degree would be advantageous. MD: A MBBS, or an equivalent medical degree.
Months of entry
January, September, April
Clinicians, scientists and students engaged in cancer research at Newcastle share a common purpose: to improve treatment outcomes for patients with cancer. Work covers a broad spectrum - understanding the biological and molecular differences between normal and malignant cells and using this knowledge to develop new anti-cancer drugs.
Our staff and postgraduate students are based in the Northern Institute for Cancer Research (NICR) or the School of Chemistry. The NICR incorporates the Newcastle Cancer Centre, a unique collaboration between Cancer Research UK and the North of England Children's Cancer Research Fund.
We are a major training base for the next generation of cancer researchers. Our Institute covers many areas of cancer research, including:
- solid tumours and leukaemias
- childhood and adult cancers
- drug discovery and early phase clinical trials
We offer approximately 15 MD, PhD and integrated MRes/PhD studentships each year, including the Newcastle Cancer Centre training programme. Projects in all research areas are available to fully-funded international students.
Exploratory biology, target and biomarker discovery; Biiomarker development; Drug development; Clinical trials
Information for international studentsTo study this course you need to meet the following English Language requirements: IELTS 6.5 overall (with a minimum of 6.5 in all other sub-skills). Pre-sessional English Language courses are not accepted as an alternative entry to this course. You may need an ATAS (Academic Technology Approval Scheme) clearance certificate.
Fees and funding
See our programme fees and funding web page.
Qualification and course duration
Course contact details
- Pauline Stephenson, Postgraduate Secretary, Northern Institute for Cancer Research
- +44 (0) 191 246 4300